We are committed to developing new chemical entities against novel biological targets to reach the large numbers of patients who are refractory to existing anti-inflammatory therapies.
Service Provider
We are committed to developing new chemical entities against novel biological targets to reach the large numbers of patients who are refractory to existing anti-inflammatory therapies.